Literature DB >> 16341612

What does the WHOQOL-Bref measure? Measurement overlap between quality of life and depressive symptomatology in chronic somatoform pain disorder.

Martin Aigner1, Sophie Förster-Streffleur, Wolfgang Prause, Marion Freidl, Maria Weiss, Michael Bach.   

Abstract

INTRODUCTION: Quality of life has become an important outcome criterion for psychiatric interventions. Especially in chronic disorders with no complete recovery, the improvement of quality of life is an important treatment goal. Nevertheless, there are methodological problems in assessing quality of life. There is a possible measurement overlap between quality of life and psychopathology, especially depression, which may invalidate research results. This study addresses the quality of life of patients with chronic somatoform pain and its relation to depressive symptoms.
METHOD: One hundred out-patients with somatoform pain disorder at the Behavioural Medicine Pain Clinic in the Department of Psychiatry of the Medical University of Vienna were diagnosed using the SCID for Diagnostic and Statistical Manual of Mental Disorder (DSM-IV). The patients filled out the World Health Organisation Quality of Life Assessment-Bref (WHOQOL-Bref) and the Beck Depression Inventory (BDI). Pain intensity (average pain, maximum pain, minimal pain) and disability (work, leisure and family life) were assessed using visual analogue scales.
RESULTS: Quality of life in somatoform pain disorder was reduced compared to the norm population, especially in the physical and psychological domains. There were highly significant negative correlations between, on the one hand, depressive symptomatology (BDI) and, on the other hand, the physical quality of life domain (r=-0.655, p<0.01), the psychological domain (r=-0.735, p<0.01), the social domain (r=-0.511, p<0.01) and the environmental domain (r=-0.561, p<0.01). In all domains of the WHOQOL-Bref and in the global score, significant differences between the group of patients with severe or very severe depressive symptoms and the group with no or only mild depressive symptoms were found. DISCUSSION: While the WHOQOL-Bref showed a poor quality of life of patients with chronic somatoform pain disorder in general and especially in the physical and in the psychological domains, the high correlation of physical and psychological quality of life scores with depressive symptomatology points to a measurement overlap. It is suggested that assessment of subjective quality of life should always be checked for the influence of depressive symptomatology on the quality of life score.

Entities:  

Mesh:

Year:  2006        PMID: 16341612     DOI: 10.1007/s00127-005-0997-8

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  23 in total

1.  Parental rearing style, premorbid personality, mental health, and quality of life in chronic regional pain: A causal analysis.

Authors:  For-Wey Lung; Yi-Lin Huang; Bih-Ching Shu; Fei-Yin Lee
Journal:  Compr Psychiatry       Date:  2004 May-Jun       Impact factor: 3.735

2.  Quality of life and its correlates in patients with bipolar disorder stabilized on lithium prophylaxis.

Authors:  Prabhat K Chand; Surendra K Mattoo; Pratap Sharan
Journal:  Psychiatry Clin Neurosci       Date:  2004-06       Impact factor: 5.188

3.  The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group.

Authors:  S M Skevington; M Lotfy; K A O'Connell
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

4.  Developing methods for assessing quality of life in different cultural settings. The history of the WHOQOL instruments.

Authors:  Suzanne M Skevington; Norman Sartorius; Marianne Amir
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-01       Impact factor: 4.328

5.  Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group.

Authors: 
Journal:  Psychol Med       Date:  1998-05       Impact factor: 7.723

6.  [Results of in- vs outpatient post-stroke rehabilitation over 6 months].

Authors:  F Bölsche; U Hasenbein; H Reissberg; A Schlote; C-W Wallesch
Journal:  Fortschr Neurol Psychiatr       Date:  2003-09       Impact factor: 0.752

7.  Quality of life in patients with schizophrenia--comparison of self-report and proxy assessments.

Authors:  Angela Becchi; Paola Rucci; Anna Placentino; Giovanni Neri; Giovanni de Girolamo
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-05       Impact factor: 4.328

8.  Quality of life of people with rheumatoid arthritis as measured by the World Health Organization Quality of Life Instrument, short form (WHOQOL-BREF): score distributions and psychometric properties.

Authors:  William J Taylor; Julie Myers; Russell T Simpson; Kathryn M McPherson; Mark Weatherall
Journal:  Arthritis Rheum       Date:  2004-06-15

9.  Judgments of quality of life of individuals with severe mental disorders: Patient self-report versus provider perspectives.

Authors:  F Sainfort; M Becker; R Diamond
Journal:  Am J Psychiatry       Date:  1996-04       Impact factor: 18.112

10.  Quality of life assessment in people living with psychosis.

Authors:  Helen Herrman; Graeme Hawthorne; Rosemary Thomas
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2002-11       Impact factor: 4.328

View more
  25 in total

1.  Quality of life, subjective well-being, and religiosity in Muslim college students.

Authors:  Ahmed M Abdel-Khalek
Journal:  Qual Life Res       Date:  2010-06-29       Impact factor: 4.147

2.  Subjective quality of life of patients with obsessive-compulsive disorder.

Authors:  Katarina Stengler-Wenzke; Michael Kroll; Herbert Matschinger; Matthias C Angermeyer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-05-23       Impact factor: 4.328

3.  [Quality of life and alexithymia in somatoform pain disorder].

Authors:  D Garcia Nuñez; M Rufer; K Leenen; K-L Majohr; H Grabe; J Jenewein
Journal:  Schmerz       Date:  2010-02       Impact factor: 1.107

4.  A comparison of two measures of quality of life of Nigerian clinic patients with type 2 diabetes mellitus.

Authors:  B A Kolawole; S K Mosaku; R T Ikem
Journal:  Afr Health Sci       Date:  2009-09       Impact factor: 0.927

5.  The relationship between depressive symptoms, illness perceptions and quality of life in ankylosing spondylitis in comparison to rheumatoid arthritis.

Authors:  Thomas Hyphantis; Konstantinos Kotsis; Niki Tsifetaki; Francis Creed; Alexandros A Drosos; André F Carvalho; Paraskevi V Voulgari
Journal:  Clin Rheumatol       Date:  2013-01-18       Impact factor: 2.980

6.  Depression as a determinant of quality of life in patients with chronic disease: data from Brazil.

Authors:  Luciane Nascimento Cruz; Marcelo Pio de Almeida Fleck; Carisi Anne Polanczyk
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-09-22       Impact factor: 4.328

7.  Quality of life of people who inject drugs: characteristics and comparisons with other population samples.

Authors:  Jane A Fischer; Sue Conrad; Alexandra M Clavarino; Robert Kemp; Jackob M Najman
Journal:  Qual Life Res       Date:  2013-01-23       Impact factor: 4.147

8.  Mental health and well-being in a 6-year follow-up of patients with depression: assessments of patients and clinicians.

Authors:  Heli Koivumaa-Honkanen; Timo K Tuovinen; Kirsi Honkalampi; Risto Antikainen; Jukka Hintikka; Kaisa Haatainen; Heimo Viinamäki
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-04-25       Impact factor: 4.328

9.  Subjective quality of life in a nationwide sample of Kuwaiti subjects using the short version of the WHO quality of life instrument.

Authors:  Jude U Ohaeri; Abdel W Awadalla; Osama M Gado
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-11-26       Impact factor: 4.328

10.  Physical activity and exercise in the treatment of depression.

Authors:  Holly Blake
Journal:  Front Psychiatry       Date:  2012-12-07       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.